BioCentury
ARTICLE | Emerging Company Profile

Scribe: engineering CRISPR’s next generation

Doudna’s latest CRISPR play uses engineered enzymes to improve therapeutic properties

October 6, 2020 10:26 PM UTC

Scribe is carving out a new space in the gene editing landscape with a next-generation version of the technology from Jennifer Doudna’s lab that substitutes engineered CRISPR enzymes for their ...



Access this Article